Who
Joel Becker
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Neuropace; President, CRM & Neuro, Integer Holdings; President, Americas, St Jude Medical.
In numbers
- Trades disclosed
- 176
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $10.9M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 31 Oct 2011
- Last trade
- 3 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 4 Sep 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,310 at $14.75 | filing |
| 3 Sep 2026filed 4 Sep 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,310 at $14.75 | filing |
| 27 Aug 2026filed 28 Aug 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $16K1,126 at $14.13 | filing |
| 27 Aug 2026filed 28 Aug 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $16K1,126 at $14.13 | filing |
| 3 Jun 2026filed 4 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $20K1,255 at $15.88 | filing |
| 3 Jun 2026filed 4 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $20K1,255 at $15.88 | filing |
| 27 May 2026filed 28 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,126 at $17.06 | filing |
| 27 May 2026filed 28 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,126 at $17.06 | filing |
| 15 May 2026filed 19 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —45,880 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —122,190 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —122,190 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —45,880 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $69K5,023 at $13.83 | filing |
| 3 Mar 2026filed 4 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $69K5,023 at $13.83 | filing |
| 27 Feb 2026filed 2 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $16K1,126 at $14.58 | filing |
| 27 Feb 2026filed 2 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $16K1,126 at $14.58 | filing |
| 27 Nov 2025filed 1 Dec 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,126 at $16.50 | filing |
| 27 Aug 2025filed 28 Aug 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $9,9991,126 at $8.88 | filing |
| 27 May 2025filed 29 May 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $14K1,126 at $12.66 | filing |
| 10 Mar 2025filed 20 Mar 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —99,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.